• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

July 30, 2004

View Archived Issues

Inhibition of beta-amyloid plaque formation by Cu/Zn chelating agent

Read More

Launch of Axid oral solution

Read More

New factor VIIa/TF inhibitors under study at Schering AG

Read More

Chinese researchers identify novel agents for renal disorders

Read More

Novel antitumor and antifungal compounds developed at Gemin X

Read More

New orexin-2 antagonists and their use in obesity and sleep disorders

Read More

New PTP-1B inhibitors described by Wyeth researchers

Read More

GSK researchers design novel thrombin/factor Xa inhibitors

Read More

Novel VEGFR inhibitors prepared and tested by ImClone researchers

Read More

Phase I results of spi-VEC vaccine for hepatitis B

Read More

Endovasc updates pipeline progress

Read More

FDA approval for Metvix

Read More

Maribavir enters phase II program in bone marrow transplant patients

Read More

Lexicon Genetics and Takeda team up on hypertension

Read More

Alimta receives positive endorsement from Advisory Committee for NSCLC

Read More

Approvable letter for Ionsys

Read More

Enanta and Shionogi enter agreement for EP-013420 in Japan and East Asia

Read More

Sunesis and Merck & Co. collaborate on discovery of novel antiviral drugs

Read More

EstroGel becomes first available transdermal estrogen gel in U.S.

Read More

Potent antiinflammatory and analgesic agent identified and tested at Orchid

Read More

Plantacor licenses preclinical cancer therapeutics from M. D. Anderson

Read More

Restructuring and R&D refocusing at Inflazyme

Read More

Completion of clinical portion of EXCEEDS phase IIIb study of Xyrem

Read More

PediaMed and Allergan enter pediatrics copromotion agreement for Tazorac

Read More

Neurokinin 1 receptor antagonist effective against postoperative fibrous adhesions

Read More

ChiRhoClin launches human secretin

Read More

Assessment of Bcl -2 family members as targets for antisense therapy in melanoma

Read More

Immunostimulatory effects of loxoribine in monocyte-derived DCs

Read More

Photodynamic therapy with Metvix shows efficacy in actinic cheilitis

Read More

MRI improvements found with a single dose of natalizumab in relapsing MS patients

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe